Soligenix Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$1.13

+0.09 (+8.65%)

As of Feb 8, 2:28 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 6 86%

Hold 1 14%

Sell 0 0%

Price Target

Analyst Price Target +3,513.3% upside

Low Target $24.77

Average Target $40.83

High Target $47.84

Current Price $1.13

Current
$1.13

Target
$40.83

$24.77 $40.83 avg $47.84

Scenario Analysis

Bear Case

$24.77

2,092.0%

Low target

Base Case

$40.83

+3,513.3%

Avg target

Bull Case

$47.84

+4,133.6%

High target

Risk/Reward

2.0x

Balanced

Price in Context

52-Week High

$43.81

-97.4% from high

52-Week Low

$22.05

+-94.9% from low

Target vs 52W High

$40.83

-6.8% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	37	68%	$257.58	+15.3%
AMGN Amgen Inc	Hold	41	54%	$190.87	-50.3%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	77%	$438.34	-8.3%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.2%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-68.8%
INSM Insmed Inc	Strong Buy	27	93%	$143.40	-4.3%
BIIB Biogen Inc	Hold	42	48%	$91.45	-54.5%